Jason Zemansky
Stock Analyst at B of A Securities
(4.84)
# 75
Out of 4,937 analysts
40
Total ratings
78.57%
Success rate
38.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $94 → $109 | $109.55 | -0.50% | 10 | Jun 11, 2025 | |
| KROS Keros Therapeutics | Downgrades: Neutral | $32 → $18 | $13.67 | +31.68% | 2 | Jun 10, 2025 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $32 → $9 | $2.86 | +214.69% | 1 | May 28, 2025 | |
| CYTK Cytokinetics | Maintains: Neutral | $62 → $54 | $34.11 | +58.31% | 4 | Apr 15, 2025 | |
| TVTX Travere Therapeutics | Maintains: Buy | $29 → $31 | $16.94 | +83.00% | 4 | Apr 1, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $22 → $17 | $9.06 | +87.64% | 5 | Feb 19, 2025 | |
| KURA Kura Oncology | Maintains: Buy | $36 → $29 | $5.55 | +422.52% | 2 | Nov 22, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $30 → $31 | $12.48 | +148.40% | 3 | Aug 15, 2024 | |
| ESPR Esperion Therapeutics | Downgrades: Underperform | $2.9 → $2.5 | $1.87 | +33.69% | 5 | Jun 20, 2024 | |
| HOWL Werewolf Therapeutics | Maintains: Buy | $9 → $10 | $1.17 | +754.70% | 4 | May 12, 2023 |
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $94 → $109
Current: $109.55
Upside: -0.50%
Keros Therapeutics
Jun 10, 2025
Downgrades: Neutral
Price Target: $32 → $18
Current: $13.67
Upside: +31.68%
Rocket Pharmaceuticals
May 28, 2025
Maintains: Buy
Price Target: $32 → $9
Current: $2.86
Upside: +214.69%
Cytokinetics
Apr 15, 2025
Maintains: Neutral
Price Target: $62 → $54
Current: $34.11
Upside: +58.31%
Travere Therapeutics
Apr 1, 2025
Maintains: Buy
Price Target: $29 → $31
Current: $16.94
Upside: +83.00%
Arcus Biosciences
Feb 19, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $9.06
Upside: +87.64%
Kura Oncology
Nov 22, 2024
Maintains: Buy
Price Target: $36 → $29
Current: $5.55
Upside: +422.52%
Syndax Pharmaceuticals
Aug 15, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $12.48
Upside: +148.40%
Esperion Therapeutics
Jun 20, 2024
Downgrades: Underperform
Price Target: $2.9 → $2.5
Current: $1.87
Upside: +33.69%
Werewolf Therapeutics
May 12, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.17
Upside: +754.70%